Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage

Item Type:Article
Title:p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage
Creators Name:Park, J.K. and Fischer, R. and Dechend, R. and Shagdarsuren, E. and Gapeljuk, A. and Wellner, M. and Meiners, S. and Gratze, P. and Al-Saadi, N. and Feldt, S. and Fiebeler, A. and Madwed, J.B. and Schirdewan, A. and Haller, H. and Luft, F.C. and Mueller, D.N.
Abstract:We investigated whether or not p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. We used double transgenic rats harboring both human renin and angiotensinogen genes (dTGRs). dTGR, with or without p38 inhibitor (BIRB796; 30 mg/kg per day in the diet), and nontransgenic Sprague-Dawley rats were studied in 2 protocols. In protocol 1 (week 7), systolic blood pressure of untreated dTGRs was 204+/-4 mm Hg, but partially reduced after BIRB796 treatment (166+/-7 mm Hg), whereas Sprague-Dawley rats were normotensive. The cardiac hypertrophy index was unchanged in untreated and BIRB796-treated dTGRs. The beta-myosin heavy chain expression of BIRB796-treated hearts was significantly lower in BIRB796 compared with dTGRs, indicating a delayed switch to the fetal isoform. BIRB796 treatment significantly reduced cardiac fibrosis, connective tissue growth factor, tumor necrosis factor-alpha, interleukin-6, and macrophage infiltration. Albuminuria was not reduced in BIRB796-treated dTGRs. Tubular and glomerular damage with tumor necrosis factor-alpha expression was unaltered, although serum creatinine and cystatin C were normalized. Renal macrophage infiltration, fibrosis, and vessel damage were reduced. In protocol 2 (week 8), we focused on mortality and arrhythmogenic electrical remodeling. Mortality of untreated dTGRs was 100% but was reduced to 10% in the BIRB796 group. Cardiac magnetic field mapping showed prolongation of depolarization and repolarization in untreated dTGRs compared with Sprague-Dawley rats with a partial reduction by BIRB796. Programmed electrical stimulation elicited ventricular tachycardias in 81% of untreated dTGRs but only in 48% of BIRB796-treated dTGRs. In conclusion, BIRB796 improved survival, target organ damage, and arrhythmogenic potential in angiotensin II-induced target organ damage.
Keywords:Angiotensin II, p38, Electrical remodeling, Cardiac and renal damage, Animals, Rats
Source:Hypertension
ISSN:0194-911X
Publisher:American Heart Association (U.S.A.)
Volume:49
Number:3
Page Range:481-489
Date:March 2007
Official Publication:https://doi.org/10.1161/01.HYP.0000256831.33459.ea
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library